Antibiotic resistance threatens treatment options
Antibiotics losing effectiveness, WHO warns
The World Health Organisation (WHO) has warned that patients are running out of treatment options as antibiotics become increasingly ineffective against infections, with the situation worsening since 2019.
WHO, in a statement on Wednesday, said common bacteria were developing high resistance to first-line and even last-resort antibiotics.
The warning was issued ahead of World Antimicrobial Resistance (AMR) Awareness Week (WAAW), observed annually from Nov. 18 to 24 to raise awareness and promote global action against drug-resistant infections.
The agency issued the alert alongside the European Centre for Disease Prevention and Control (ECDC) following an assessment of progress towards reducing infections caused by antibiotic-resistant bacteria, commonly known as superbugs.
According to the assessment, infections caused by Klebsiella pneumoniae, a common hospital-acquired bacterium, increased by an estimated 72 per cent between 2019 and 2025, instead of meeting the target of a five per cent reduction.
Similarly, infections caused by E. coli resistant to commonly used antibiotics known as cephalosporins rose by more than 16 per cent, against a target of a 10 per cent reduction.
WHO said resistance to key antibiotics was detected in at least half of the samples of Klebsiella pneumoniae and Acinetobacter in about half of the countries in Europe.
Dr Marc-Alain Widdowson, WHO/Europe’s Head of Health Security, said antibiotics commonly prescribed for serious hospital infections were failing in many countries.
He explained that when first-line antibiotics failed, doctors resorted to stronger drugs, including carbapenems, which were usually reserved for severe infections.
However, he warned that resistance to these stronger drugs would leave doctors with only a limited number of expensive last-resort treatments, which were not readily available in every country.
Widdowson said patients whose infections did not respond to initial antibiotic treatment were more likely to die in hospitals.
WHO also noted that 16 of the 51 countries assessed still lacked standardised national approaches and coordination to tackle antimicrobial resistance.
The agency said inadequate blood testing in hospitals often forced doctors to prescribe antibiotics without knowing which drugs would effectively treat the infections.
It warned that this increased the risk of patients receiving ineffective treatment and made it difficult for health authorities to monitor the spread of resistance and assess intervention efforts.
WHO stressed that improved testing would help patients receive appropriate treatment earlier while providing countries with reliable data to tackle the threat.
However, the agency reported some progress, noting that the estimated rate of bloodstream infections caused by resistant Acinetobacter had almost halved from the high levels recorded in 2021 during the COVID-19 pandemic.



